| ATC | B/G | Ingredients | code | Registration Nb | Name | Dosage | Presentation | Form | Route | Agent | Laboratory | Country | Price | Pharmacist Margin | Stratum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| B02BX05 | B | Eltrombopag Olamine - 25mg | 11625 | 120416/1 | REVOLADE | 25mg | 28 | Tablet, film coated | Oral | Khalil Fattal & Fils S.A.L. | Novartis Pharmaceuticals Manufacturing LLC | Slovenia | 75,701,015 L.L | 2.44 | E2 | Novartis Pharma AG | Switzerland | 12/12/20 |
| ATC | B/G | Ingredients | code | Registration Nb | Name | Dosage | Presentation | Form | Route | Agent | Laboratory | Country | Price | Pharmacist Margin | Stratum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| B02BX05 | G | Eltrombopag Olamine - 25mg | 12355 | 148623/1 | APO-ELTROMBOPAG | 25mg | 28 | Tablet | Oral | Promopharm S.A.R.L. | Apotex Inc | Canada | 41,496,211 L.L | 10.71 | E1 | Apotex Inc | Canada | 12/12/20 |

